Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents

Accounts of Chemical Research
Guillaume MerceyPierre-Yves Renard

Abstract

Since the September 11, 2001, terrorist attacks in the United States, the specter of a chemical threat against civilian populations has renewed research interest in chemical warfare agents, their mechanisms of action, and treatments that reverse their effects. In this Account, we focus specifically on organophosphorus nerve agents (OPNAs). Although some OPNAs are used as pest control, the most toxic chemicals in this class are used as chemical warfare agents in armed conflicts. The acute toxicity of OPNAs results from the irreversible inhibition of acetylcholinesterase (AChE, EC 3.1.1.7) via the formation of a covalent P-O bond at the serine hydroxyl group in the enzyme active site. AChE breaks down the neurotransmitter acetylcholine at neuronal synapses and neuromuscular junctions. The irreversible inhibition of AChE causes the neurotransmitter to accumulate in the synaptic cleft, leading to overstimulation of cholinergic receptors, seizures, respiratory arrest, and death. The current treatment for OPNA poisoning combines an antimuscarinic drug (e.g., atropine), an anticonvulsant drug (e.g., diazepam), and an AChE reactivator of the pyridinium aldoxime family (pralidoxime, trimedoxime, obidoxime, HI-6, HLö-7). Because of their...Continue Reading

References

Aug 15, 1986·Carbohydrate Research·E HeldmanE S Rachaman
Aug 27, 2003·Neurochemical Research·Koichi SakuradaTakehiko Takatori
Sep 1, 1955·Biochimica Et Biophysica Acta·I B WILSON, B GINSBURG
Dec 1, 1955·British Journal of Pharmacology and Chemotherapy·A F CHILDSJ P RUTLAND
Sep 25, 2003·Bioorganic & Medicinal Chemistry Letters·Kamil KucaJirí Kassa
Jun 23, 2004·Neurobiology of Disease·Praveen BallabhMaiken Nedergaard
Sep 24, 2004·Basic & Clinical Pharmacology & Toxicology·Jirí CabalJ Kassa
Dec 24, 2005·Nature Reviews. Neuroscience·N Joan AbbottElisabeth Hansson
Jun 14, 2006·Archives of Toxicology·Donald M MaxwellRichard E Sweeney
Nov 23, 2006·Toxicology and Applied Pharmacology·F WorekH Thiermann
Mar 21, 2007·Journal of Applied Toxicology : JAT·F WorekH Thiermann
Apr 26, 2007·Clinical Medicine & Research·Biljana Antonijevic, Milos P Stojiljkovic
Aug 21, 2007·Lancet·Michael EddlestonAndrew H Dawson
Apr 9, 2008·Current Medicinal Chemistry·D E LorkeK Tekes
Jan 7, 2009·Bioorganic & Medicinal Chemistry Letters·Hee Chun JeongYoung-Sik Jung
May 29, 2009·Basic & Clinical Pharmacology & Toxicology·Kamil KucaMartina Hrabinova
Jun 30, 2009·Pharmacotherapy·Aaron M CookJimmi Hatton
Jun 30, 2009·Journal of the American College of Radiology : JACR·William G Bradley
Sep 19, 2009·Toxicology·Elisabet ArturssonFredrik Ekström
Feb 10, 2010·Chemistry : a European Journal·Ludivine Louise-LerichePierre-Yves Renard
Feb 17, 2010·Chemico-biological Interactions·James C DemarRichard K Gordon
Mar 17, 2010·Chemico-biological Interactions·Gregory E GarciaVenee I Morthole
Mar 27, 2010·Chemico-biological Interactions·Patrick MassonOksana Lockridge
Apr 23, 2010·Journal of Medicinal Chemistry·Eugénie CarlettiFlorian Nachon

❮ Previous
Next ❯

Citations

Sep 19, 2012·The Journal of Physical Chemistry. B·Gulseher Sarah SirinYingkai Zhang
Feb 16, 2013·Organic Letters·Joseph J Topczewski, Daniel M Quinn
May 10, 2013·Chemical Research in Toxicology·Carter W AbneyRudolph C Johnson
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Mohammd MoshiriMahdi Balali-Mood
Apr 23, 2013·Pharmacology & Therapeutics·Franz Worek, Horst Thiermann
Feb 24, 2015·Toxicology and Applied Pharmacology·Hayden R SchmidtErica A Fradinger
Oct 24, 2015·Chemico-biological Interactions·Nellore Bhanu ChandarBishwajit Ganguly
May 7, 2016·Annals of the New York Academy of Sciences·Janice E ChambersHoward W Chambers
Jun 22, 2016·Annals of the New York Academy of Sciences·Qinggeng ZhuangChristopher M Hadad
Jun 29, 2016·Archives of Toxicology·Franz WorekHorst Thiermann
Jul 28, 2016·Journal of Molecular Graphics & Modelling·Rodrigo OchoaAndres F Zuluaga
May 19, 2017·Disaster Medicine and Public Health Preparedness·Matthew John WatermeyerAbdullah Ebrahim Laher
Mar 28, 2017·Chemical Society Reviews·N Scott BobbittRandall Q Snurr
Jan 21, 2017·Chembiochem : a European Journal of Chemical Biology·Thomas DriantEtienne Derat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.